Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer
Clinical trial NCT01439191 · COMPLETED
Trial details
- NCT number
- NCT01439191
- Sponsor
- Shanghai CP Guojian Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2007-02-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.